Ovoca Bio
Ireland · Pharma & Healthcare
LeaveRussia detail: Withdrawal
Ovoca Bio is a clinical-stage biopharmaceutical company with a focus on women's health. Founded and incorporated in Ireland.
Decision trail
Decision date 10/03/2023 · Reference ↗
Ovoca Bio PLC agrees to dispose of some of its Russian assets to Desirix LLC for EUR1.1 million. Upon completion, all operational activities of Ovoca in Russia will cease and its Russian subsidiary, IVIX LLC, will be transferred to an inactive, non-operating status.
Status history since 2022
- 03/08/2026 — exited · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional